Clinical Trials Browser

OTHER × berzosertib × Clear all

NCT04266912 2025-11-25

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

Phase 1/2 Active not recruiting

23 enrolled 11 charts

Neoplasm Metastasis

NCT03718091 2023-07-07

M6620 (VX-970) in Selected Solid Tumors

Phase 2 Completed

30 enrolled 15 charts

Leiomyosarcoma, Osteosarcoma